Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Drugs Dermatol ; 20(3): 260-267, 2021 03 01.
Article in English | MEDLINE | ID: mdl-33683072

ABSTRACT

BACKGROUND: Minimally invasive alternative approaches to treat non-melanoma skin cancers remain limited and unproven. OBJECTIVE: We aim to assess the efficacy of varying combinations of anti-tumor agents—imiquimod 5% cream, 5-fluorouracil 2% solution, and tretinoin 0.1% cream—with brief cryotherapy in treating non-melanoma skin cancers. METHODS: This retrospective study included 690 cases of non-melanoma skin cancers in 480 patients who received a diagnosis of a basal cell carcinoma or squamous cell carcinoma during a ten-year period. During treatment period, patients applied 30 applications of one of three combinations (imiquimod/tretinoin, 5-fluorouracil/tretinoin, or imiquimod/5-fluorouracil/tretinoin) and had cryotherapy every 2 weeks. Each patient had a clinical examination at least three years post-treatment or documented treatment failure. Clearance was defined by a lack of persistence or recurrence for 3 years following the completion of treatment. The likelihood of lesion clearance was evaluated using multivariable logistic regression analysis. RESULTS: A total of 186 cases (97; basal cell carcinoma and 89; squamous cell carcinoma) in 133 patients [37% women and 63% men; median (interquartile range) age, 77 (69, 83) years] met the inclusion criteria. Multivariable logistic regression analysis adjusting for clinical and lesion variables demonstrated that, relative to the imiquimod/5-fluorouracil/tretinoin treatment approach, imiquimod/ tretinoin (odds ratio, 0.05; 95% confidence interval, 0.00-0.99) and 5-fluorouracil/tretinoin (0.02; 0.00–0.45) were associated with lower likelihoods of lesion clearance. Likewise, morpheaform basal cell carcinoma had a lower probability of clearance (0.05; 0.00–0.72). CONCLUSIONS: The combination of imiquimod/5-fluorouracil/tretinoin with cryotherapy had high clearance rates and was the most effective treatment regimen. J Drugs Dermatol. 2021;20(3):260-267. doi:10.36849/JDD.5427.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinoma, Basal Cell/therapy , Carcinoma, Squamous Cell/therapy , Cryotherapy/methods , Neoplasm Recurrence, Local/epidemiology , Skin Neoplasms/therapy , Administration, Cutaneous , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/economics , Carcinoma, Basal Cell/economics , Carcinoma, Basal Cell/epidemiology , Carcinoma, Squamous Cell/economics , Carcinoma, Squamous Cell/epidemiology , Combined Modality Therapy/economics , Combined Modality Therapy/methods , Cost-Benefit Analysis , Cryotherapy/economics , Female , Fluorouracil/administration & dosage , Fluorouracil/economics , Humans , Imiquimod/administration & dosage , Imiquimod/economics , Male , Middle Aged , Neoplasm Recurrence, Local/economics , Neoplasm Recurrence, Local/prevention & control , Retrospective Studies , Skin Neoplasms/economics , Skin Neoplasms/epidemiology , Treatment Outcome , Tretinoin/administration & dosage , Tretinoin/economics
2.
J Drugs Dermatol ; 18(11): 1090-1096, 2019 Nov 01.
Article in English | MEDLINE | ID: mdl-31738492

ABSTRACT

Background: Hypopigmentation is a common cutaneous manifestation that frequently poses a therapeutic challenge for dermatologists. Current treatments have varying efficacies and rarely provide patients with long-term results. However, new treatments are emerging, and head-to-head studies comparing these treatments are warranted. Methods & Materials: In this prospective, Institutional Review Board (IRB)-approved, double-blinded study, 40 subjects with moderate to severe hypopigmentation were randomized into 1 of 4 treatment arms; non-ablative fractional laser, ablative fractional laser, ablative fractional laser with laser-assisted delivered bimatoprost, and an epidermal harvesting system. Results: All patients in this study showed improvement regardless of the treatment modality. The average improvement score was calculated on a 0 to 4 scale, and Group 3 (fractional ablative laser and bimatoprost) was found to have a significantly higher average improvement than all other treatments, with 76% of the patients exhibiting at least a grade 3 (over 50%) improvement over the treatment course. Group 1 (non-ablative fractional) also had a significantly higher average score compared with group 2 (fractional ablative laser). Conclusion: New and emerging therapies have shown promise in helping re-pigmentation of cutaneous hypopigmentation. In this head-to-head trial, it was shown that laser-assisted delivery of bimatoprost had a greater statistically significant improvement compared with 3 possible treatment modalities for stimulation of pigment in medical and cosmetic hypopigmentation. J Drugs Dermatol. 2019;18(11):1090-1096.


Subject(s)
Bimatoprost/administration & dosage , Dermatologic Agents/administration & dosage , Facial Dermatoses/surgery , Hypopigmentation/surgery , Lasers, Solid-State/therapeutic use , Melanocytes , Adult , Double-Blind Method , Female , Humans , Male , Middle Aged , Prospective Studies , Tissue and Organ Harvesting , Treatment Outcome
3.
Skin Appendage Disord ; 5(3): 169-171, 2019 Apr.
Article in English | MEDLINE | ID: mdl-31049341

ABSTRACT

Retronychia is a frequently misdiagnosed nail disorder characterized by proximal ingrowth of the nail into the proximal nail plate. Often presenting with chronic paronychia, retronychia is commonly misdiagnosed and treated ineffectively with antimicrobials. The main cause is repeated micro-trauma to the affected nail, therefore a thorough history of exposures and insults to the toenail is crucial in identifying the cause of this nail abnormality. Herein, we describe a case of a UPS employee who presented with a painful nail after dropping a package on her foot that was unresponsive to medical treatment for 2 years. This case highlights the importance of taking a thorough history and physical examination for diagnosing retronychia.

4.
J Drugs Dermatol ; 18(2): 211-212, 2019 Feb 01.
Article in English | MEDLINE | ID: mdl-30811150

ABSTRACT

A 44-year-old woman with a history of asthma, hypercholesterolemia, and impaired glucose tolerance presented with severely painful and intensely pruritic plantar dermatitis for more than two years that impaired her ability to walk.


Subject(s)
Anti-Asthmatic Agents/administration & dosage , Antibodies, Monoclonal/administration & dosage , Eczema, Dyshidrotic/diagnosis , Eczema, Dyshidrotic/drug therapy , Foot/pathology , Severity of Illness Index , Adult , Antibodies, Monoclonal, Humanized , Female , Humans , Remission Induction/methods
5.
Dermatol Pract Concept ; 8(3): 180-183, 2018 Jul.
Article in English | MEDLINE | ID: mdl-30116660

ABSTRACT

Lichen planus-like keratosis (LPLK) is an involuting cutaneous lesion often presenting between the fifth and seventh decades of life. These lesions typically appear abruptly as a solitary macule, papule, or plaque that continuously evolves as it undergoes regression. Clinical and dermoscopic features of LPLK can mimic both benign and malignant lesions, often prompting biopsy for accurate diagnosis. We describe a case of LPLK developing in a patient with a history of multiple skin cancers, including melanoma. Dermoscopy revealed peripheral granules and a central area with pinkish-brown pigmentation and a disorganized pattern with shiny white structures and rosettes. Handheld reflectance confocal microscopy (RCM) showed a typical honeycomb pattern with millia-like cysts and comedo-like openings, and lacked pagetoid and dendritic cells. Based on the benign features seen with RCM, the lesion was followed until complete regression was observed. In conclusion, we describe a case of LPLK with clinically and dermoscopically indeterminate features that was successfully monitored with RCM. We intend to highlight the utility of RCM as a diagnostic aid in equivocal lesions in order to prevent unnecessary excisional procedures.

SELECTION OF CITATIONS
SEARCH DETAIL
...